Clinical Research Directory

Inclusion Criteria: * Male or female aged 18 years or older. * Patient with a confirmed diagnosis of chronic obstructive pulmonary disease (COPD), classified according to the GOLD ABE classification, who has experienced at least one COPD exacerbation within the previous 12 months. * Able and willing to provide written informed consent. * Able to comply with the telemonitoring procedures, including: * Performing physiological measurements on a regular basis; * Completing the required questionnaires. * Covered by a valid health insurance or social security scheme. Exclusion Criteria * Receiving long-term oxygen therapy (LTOT) or non-invasive ventilation (NIV), regardless of the duration since prescription. * Presence of severe, unstable comorbidities that may interfere with the study outcomes, including but not limited to: * Decompensated heart failure; * Chronic kidney disease; * Asthma; * Other restrictive pulmonary diseases; * Psychotic mental disorders. * Participation in another interventional clinical study within the month preceding enrollment or during the study period. * Unavailable for follow-up or planning to relocate before completion of study participation. * Protected populations, including: * Pregnant or breastfeeding women, or women planning to become pregnant during the study period. For women of childbearing potential not using effective contraception, pregnancy will be ruled out by a urine or blood human chorionic gonadotropin (hCG) test before enrollment. * Individuals deprived of liberty by judicial or administrative decision, or individuals under legal protection measures.